NEOPHORE
NeoPhore is a provider of novel small molecule therapies intended to treat cancer through stimulation of the immune system.The company's small molecule therapies target genetic mechanisms in order to create neoantigen which is known to stimulate the immune system and potentially be a weak spot in a tumor cell's defense mechanisms, enabling cancer patients to get treated and achieve improved clinical outcomes.
NEOPHORE
Industry:
Biotechnology Simulation Therapeutics Translation Service
Founded:
2017-11-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.neophore.com
Total Employee:
1+
Status:
Active
Contact:
+44 (0)1223 804250
Email Addresses:
[email protected]
Total Funding:
25.07 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Universal Analytics Apache Mobile Non Scaleable Content Microsoft Exchange Online
Current Advisors List
Current Employees Featured
Founder
Investors List
2invest
2invest investment in Series B - NeoPhore
Astellas Venture Management
Astellas Venture Management investment in Series B - NeoPhore
3B Future Health Fund
3B Future Health Fund investment in Series B - NeoPhore
Claris Ventures
Claris Ventures investment in Series B - NeoPhore
Sixth Element Capital
Sixth Element Capital investment in Series B - NeoPhore
Innovate UK
Innovate UK investment in Grant - NeoPhore
Sixth Element Capital
Sixth Element Capital investment in Venture Round - NeoPhore
Official Site Inspections
http://www.neophore.com Semrush global rank: 5.48 M Semrush visits lastest month: 1.56 K
- Host name: kisscab2.miniserver.com
- IP address: 89.200.137.201
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "NeoPhore"
NeoPhore - Crunchbase Company Profile & Funding
NeoPhore is a provider of novel small molecule therapies intended to treat cancer through stimulation of the immune system.See details»
NeoPhore 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for NeoPhore. Use the PitchBook Platform to explore the full profile.See details»
NeoPhore Company Profile - Office Locations, Competitors ... - Craft
NeoPhore has 5 employees across 2 locations and $24.97 m in total funding,. See insights on NeoPhore including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
LIFTT - Neophore
Feb 1, 2024 NeoPhore is a company engaged in the development of immuno-oncology therapies targeting DNA mismatch repair components, an approach that has demonstrated validity in both clinical and pre-clinical studies. This strategy …See details»
NeoPhore - VentureRadar
NeoPhore is discovering medicines that stimulate neoantigen creation in cancer cells marking them for attack by a patient's own immune system. NeoPhore’s drugs are designed to …See details»
NeoPhore - Products, Competitors, Financials, Employees, …
NeoPhore is developing a pipeline of highly validated, first-in-class small molecule drugs targeting proteins across the MMR pathway to improve the efficacy and durability of revolutionary …See details»
NeoPhore - Claris Ventures
NeoPhore targets the dynamics of cancer neoantigen evolution and aims to make effective, well-tolerated medicines that will become a key part of the next-generation of cancer …See details»
About - NeoPhore
Discovering drugs that create neoantigens - The immune system can both detect and fight cancer, but effective cancer immunity relies strongly on the presence of cancer neoantigens.See details»
A Brief History of NeoPhore – CanvasBusinessModel.com
Dec 19, 2024 A Brief History of NeoPhore Founded in 2015 by a team of innovative researchers and scientists, NeoPhore has quickly become a leader in the field of cancer immunotherapy. …See details»
NeoPhore: Cambridge startup secures £15M to develop advance …
NeoPhore: Cambridge startup secures £15M to develop advance drugs for treating cancer NeoPhore is a Cambridge-based company focused on the discovery and development of …See details»
NeoPhore - Team | Neophore
Led by experienced biotech executives, NeoPhore conducts cutting-edge cancer research with world-leading scientists and a board of professional investors and directors.See details»
NeoPhore - Funding, Financials, Valuation & Investors
NeoPhore is a provider of novel small molecule therapies intended to treat cancer through stimulation of the immune system.See details»
NeoPhore Announces £15.2m Financing to Advance DNA …
Mar 9, 2021 Round led by Claris Ventures with 2Invest, 3B Future Health Fund and Astellas Venture Management CAMBRIDGE, England, March 9, 2021 /PRNewswire/ — NeoPhore …See details»
Company News - NeoPhore
Dec 5, 2018 Our news section provides the latest updates from the company and other media coverage. Select any of the titles to read the original press release or article.See details»
Neophore appoints Michael Shih as Chief Executive Officer
London UK, 16 December 2024 – NeoPhore Limited, a small molecule neoantigen immuno-oncology company, today announces the appointment of Michael Shih as Chief Executive …See details»
NeoPhore raises an additional £9.6m (USD $12.2m) Series B …
Feb 1, 2024 NeoPhore’s first-in-class MMR inhibitors induce neoantigen expression and increase immunogenicity in solid tumours that become exquisitely sensitive to immunotherapy. …See details»
Phosphorex, NOF CORPORATION, NeoSome Life Sciences, …
11 hours ago HOPKINTON, Mass., May 8, 2025 /PRNewswire/ -- In a groundbreaking collaboration, Phosphorex, NOF CORPORATION, NeoSome Life Sciences, NanoImaging …See details»
NeoPhore - Contacts, Employees, Board Members, Advisors
NeoPhore is a provider of novel small molecule therapies intended to treat cancer through stimulation of the immune system.See details»
UK's NeoPhore pioneers new approach to cancer immunotherapy
2 days ago A newly launched UK biotech is looking to develop a new approach to immunotherapy, based around a seemingly paradoxical idea that stimulating cancer makes …See details»
Science | Neophore
Discovering drugs that create neoantigens - The immune system can both detect and fight cancer, but effective cancer immunity relies strongly on the presence of cancer neoantigens.See details»